Skip to content
Screener

Perrigo Company PRGO Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$1.0BMiss by $48.8M
EPS$0.80Beat by $0.05
Revenue estimate$1.1B
EPS estimate$0.75

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$991.5M
EPS estimate$0.52

Financials

Q3 2025

Income statement

See full
Revenue$1.0B-4.1%
Gross profit$377.1M-6.8%
Operating income$72.6M-9.7%
Net income$7.5M+136%
EPS (diluted)$0.05+133%

Balance sheet

See full
Cash & equivalents$432.1M-70.5%
Total debt$3.9B-28.2%
Total equity$4.4B-2.6%
Total assets$10.1B-10.0%

Cash flow

See full
Operating cash flow$51.7M+22.5%
CapEx$21.9M-19.2%

Valuation & ratios

Valuation

as of 09/27/25
See full
Market cap$3.06B-14.8%
Enterprise value$6.51B-13.6%
P/S0.7×-0.1×

Profitability

See full
Gross margin35.5%-0.6pp
Operating margin6.5%—
Net margin-1.2%-0.5pp

Returns & leverage

See full
Return on equity-1.1%-0.5pp
Debt / equity0.9×-0.3×
Current ratio2.5×0.0×

Segments

By product

See full
Upper Respiratory$209.8M+1.4%
Healthy Lifestyle$130.3M-2.8%
Digestive Health$116.1M-5.2%
Women's Health$48.9M-2.6%

FAQ

When did Perrigo Company report Q3 2025 earnings?
Perrigo Company (PRGO) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Perrigo Company's Q3 2025 revenue and EPS?
Perrigo Company reported revenue of $1.0B and eps of $0.80 for Q3 2025.
Did Perrigo Company beat estimates in Q3 2025?
Revenue missed the consensus estimate of $1.1B by $48.8M. EPS beat the consensus estimate of $0.75 by $0.05.
How did Perrigo Company's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.1% from $1.1B a year earlier and eps declined 1.2% from $0.81.
Where can I find Perrigo Company's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001585364-25-000153) and the 10-Q periodic report (0001585364-25-000156) directly on SEC EDGAR. The filing index links above go to sec.gov.